<- Back to digest

Acta Orthopaedica - 2026-10-19 - Journal Article

Plasma calprotectin as infection biomarker in hip fracture patients: a prospective cohort study.

Pyrhönen HS, Tham J, Stefánsdóttir A, Persson A, Malmgren L, Rogmark C

prospective cohortLOE IIn = 166 (analyzed from 550 screened)30 days postoperative

Topics

trauma
PMID: 42894498DOI: 10.2340/17453674.2026.46719View on PubMed ->

Key Takeaway

Plasma calprotectin measured on postoperative day 3 achieved the highest AUC of 0.70 for detecting infection within 7 days after hip fracture surgery, outperforming PCT (AUC 0.48), CRP (AUC 0.56), and matching WBC count (AUC 0.69).

Summary Depth

Choose how much analysis to show on this article page.

Summary

This prospective cohort study evaluated whether plasma calprotectin measured on postoperative day 3 outperforms PCT, CRP, and WBC count in detecting infections within 30 and 7 days after hip fracture surgery in patients aged ≥65 years. Among 166 analyzed patients (median age 85), 19% developed infection within 30 days and 12% within 7 days. Calprotectin demonstrated the highest AUC for both endpoints (0.66 at 30 days, 0.70 at 7 days), with the largest statistically significant difference versus PCT at 7 days (ΔAUC 0.22, CI 0.05–0.39), though all biomarkers showed only moderate discriminatory ability.

Key Limitation

Only 166 of 550 enrolled patients were analyzed, and the exclusion rationale is not fully detailed, creating a high risk of selection bias that undermines generalizability of the biomarker performance estimates.

Original Abstract

BACKGROUND AND PURPOSE

We aimed to compare the diagnostic performance of plasma calprotectin in detecting infections following hip fracture surgery with 3 other biomarkers: procalcitonin (PCT), C-reactive protein (CRP), and white blood cell (WBC) count.

METHODS

This prospective cohort study included surgically treated hip fracture patients aged ≥ 65 years, admitted to our department from April 2023 to August 2024. Plasma calprotectin, PCT, CRP, and WBC count were measured on postoperative day 3. The outcome was any infection within 30 days (primary) and 7 days (secondary). Biomarker performance was evaluated using receiver operating characteristic analyses in a comparative framework.

RESULTS

166/550 individuals were analyzed (median age 85 years, 68% women). 19% (n = 31) and 12% (n = 20) had infection within 30 and respectively 7 days. For 30-day infections, calprotectin showed highest area under the curve (AUC) of 0.66 (95% confidence interval [CI] 0.54-0.77), followed by WBC count 0.60 (CCI 0.48-0.72), CRP 0.53 (CI 0.42-0.63), and PCT 0.51 (CI 0.40-0.63). Difference in AUC was largest between calprotectin and PCT (0.14, CI 0.00-0.29), followed by CRP (0.12, CI -0.01 to 0.26), while similar to WBC count (0.06, CI -0.05 to 0.16). For 7-day infections, AUCs were as following: calprotectin 0.70 (CI 0.58-0.82), WBC count 0.69 (CI 0.56-0.81), CRP 0.56 (CI 0.42-0.69), and PCT 0.48 (CI 0.33-0.63). Difference in AUC was largest between calprotectin and PCT (0.22, CI 0.05-0.39), followed by CRP (0.15, CI -0.02 to 0.31), while WBC count was similar (0.01, CI -0.09 to 0.12).

CONCLUSION

Calprotectin demonstrated a trend towards superior discriminatory ability for infections compared with PCT and CRP, particularly for infections within 7 days. Calprotectin provided moderate diagnostic accuracy, likewise WBC count.